GlassScriptPrepare for your visit
Li Kuo Kong
Infectious Disease · Pleasanton, CA · NPI 1518931047
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$475.10
in general payments reported to CMS, 2019-2025 · $23.51 in 2025
The $23.51 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Who reported paying
General payments only, top 6 by amount.
- Merck Sharp & Dohme LLC $146.44
- Oxford Immunotec USA INC $113.86
- Abbvie INC. $95.13
- Melinta Therapeutics, LLC $72.31
- La Jolla Pharmaceutical Company $23.85
- Shionogi INC $23.51
Drugs and devices associated with these payments
Vabomere Xerava Fetroja
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Li Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/492177/li-kuo-kong